Fennec’s hearing loss drug for cancer patients wins breakthrough FDA nod
Pharmaceutical Technology
SEPTEMBER 23, 2022
The current standard of care for many cancers is cisplatin chemotherapy or platinum therapy. Additionally , loss of hearing at a young age is associated with impaired communication, cognitive impairment, poorer mental health and quality of life. In 2018, the FDA had granted Pedmark a breakthrough orphan drug designation.
Let's personalize your content